Crossmark

Predictive factors of intracranial bleeding in head trauma patients receiving antiplatelet therapy admitted to an emergency department

Crossref DOI link: https://doi.org/10.1186/s13049-018-0515-0

Published Online: 2018-06-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moustafa, Farès https://orcid.org/0000-0003-0949-1558
Roubin, Jean

Pereira, Bruno

Barres, Alain

Saint-Denis, Jennifer

Perrier, Christophe

Mondet, Marine

Dutheil, Frederic

Schmidt, Jeannot
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

Received: 8 March 2018

Accepted: 8 June 2018

First Online: 19 June 2018

Ethics approval and consent to participate

: This analysis was approved by the appropriate regional French research ethics committee (CPP Sud-Est VI, IRB number: 00008526–2013/CE37). All patients (or their legal power of attorney) were informed of the potential use of their personal data and none opposed consent.

: No individual person’s data.

: Dr. Moustafa has served as a consultant for Bayer HealthCare Pharmaceuticals and Sanofi, been a speaker for Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Daiichi-Sankyo and Sanofi, and has received grants from Sanofi, Bayer HealthCare, and LFB.Dr. Schmidt has received payments for board membership from Bayer, Daichi, Lilly, and Pfizer, as well as personal compensation from Biomerieux, Bohringer Ingelheim, Sanofi, and Novartis.All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.